SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,580.54 0.00
( 0.00%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

65,657.92 638.97
(0.98%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.65 -0.17
(-0.17%)

EUR-INR

109.56 -0.37
(-0.34%)

GBP-INR

127.74 -0.44
(-0.34%)

JPY-INR

0.61 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Elantas Beck India Ltd

Industry : Chemicals

BSE Code

ISIN Demat

Book Value()

500123

INE280B01018

1392.5191273

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ELANTAS

61.45

10911.3

EPS(TTM)

Face Value()

Div & Yield %

223.99

0.05

Back

Colinz Laboratories standalone net profit rises 1900.00% in the June 2026 quarter

Jul 31,2026

Net profit of Colinz Laboratories rose 1900.00% to Rs 2.40 crore in the quarter ended June 2026 as against Rs 0.12 crore during the previous quarter ended June 2025. Sales declined 21.02% to Rs 1.24 crore in the quarter ended June 2026 as against Rs 1.57 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.24	1.57	-21
OPM %	4.84	8.28	-
PBDT	0.18	0.20	-10
PBT	0.14	0.16	-13
NP	2.40	0.12	1900

73,580.54 0.00 ( 0.00%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

65,657.92 638.97 (0.98%)

10,680.49 -24.77 (-0.23%)

95.65 -0.17 (-0.17%)

109.56 -0.37 (-0.34%)

127.74 -0.44 (-0.34%)

0.61 0.00 (-0.29%)